Scalp hair exam to monitor pemphigus activity and remission
Part of Immune system & allergy, Skin clinical trials.
This study uses a special microscope to look at your scalp hair (trichoscopy) to see if it can help track whether your pemphigus vulgaris is active or in remission. It also checks your blood to see if the findings match your immune system's activity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with pemphigus vulgaris (confirmed by skin biopsy).
- Your pemphigus is either active or in remission.
- You have not been treated with rituximab before.
- You do not have other skin diseases or autoimmune diseases.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how Pemphigus Vulgaris (a rare blistering skin condition) affects gum health. Researchers will check your teeth and gums to see if the disease is linked to gum problems.
This trial tests a new drug called CM313 for people with moderate to severe pemphigus, a blistering skin condition. It's for patients who haven't had this treatment before and may have not responded well to other therapies.
This study compares a tailored “maintenance” treatment plan to the usual standard care in adults with newly diagnosed pemphigus (PV or PF). It aims to see whether the personalized approach can help control the disease while reducing the burden of long-term treatment.
This Phase 1/2 trial tests the safety and dosing of genetically modified immune cells made from your own blood (autologous CAR T or related cells) for active pemphigus vulgaris. It may help control disease that is not adequately managed with standard medicines.
This study is for adults with certain autoimmune blistering skin conditions. Researchers want to better understand and test treatments that could improve symptoms and healing for people with these specific diseases.
This study tests a new drug, CM313, for people with moderate to severe pemphigus (a blistering skin disease). It aims to see if the drug can help heal the blisters and sores.
Hear when a new Pemphigus Vulgaris (PV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.